Courtney Orazio > Goodwin > Boston, United States > Lawyer Profile
Goodwin Offices
100 NORTHERN AVENUE
BOSTON MA 02210
MASSACHUSETTS
United States
- Firm Profile
- Go to...
- Position
- Career
- Education
Courtney Orazio

Position
Partner
Career
Courtney Orazio is a partner in the firm’s Complex Litigation & Dispute Resolution practice and a member of the firm’s Life Sciences Disputes group. Her practice focuses on government and internal investigations, white collar criminal defense, regulatory enforcement proceedings, securities litigation, and corporate governance matters, with clients including companies, boards, and individuals in the healthcare, life sciences, technology, and financial industries.
Courtney represents companies and their directors and officers before federal and state regulators, including the DOJ and the SEC, in connection with investigations into financial accounting improprieties, securities fraud, insider trading, healthcare fraud, and alleged False Claims Act violations. She regularly conducts internal corporate investigations for companies and their boards and audit committees in financial accounting and corporate governance-related matters. Courtney also counsels clients on regulatory compliance, disclosure issues, and litigation risk management.
Courtney is a seasoned trial lawyer who has experience representing clients at trial in civil and criminal matters in both state and federal court.
Education
JD, Columbia Law School (James Kent Scholar) 2014 / BA, Bucknell University (summa cum laude) 2009
Top Tier Firm Rankings
- Industry focus > Cannabis
- Dispute resolution > Product liability, mass tort and class action - defense: consumer products (including tobacco)
- Intellectual property > Patents: licensing
- M&A/corporate and commercial > Private equity buyouts: middle-market (Up to $500m)
- Real estate > Real estate investment trusts (REITs)
- Media, technology and telecoms > Technology transactions
- M&A/corporate and commercial > Venture capital and emerging companies
Firm Rankings
- Finance > Capital markets: equity offerings
- Dispute resolution > E-discovery
- Labor and employment > ERISA litigation
- Finance > Fintech
- Healthcare > Life sciences
- Dispute resolution > M&A litigation: defense
- Intellectual property > Patents: litigation (full coverage)
- Real estate > Real estate
- Dispute resolution > Securities litigation: defense
- Intellectual property > Trade secrets (litigation and non-contentious matters)
- M&A/corporate and commercial > Shareholder activism
- Dispute resolution > Appellate: courts of appeals / Appellate: supreme courts (states and federal)
- Finance > Capital markets: debt offerings
- International trade and national security > CFIUS
- Finance > Commercial lending
- M&A/corporate and commercial > Corporate governance
- Labor and employment > Employee benefits, executive compensation and retirement plans: transactional
- Dispute resolution > Financial services litigation
- Antitrust > Merger control
- Investment fund formation and management > Private equity funds (including venture capital)
- Dispute resolution > Product liability, mass tort and class action - defense: consumer products (including tobacco)
- Tax > US taxes: non-contentious
- Labor and employment > Workplace and employment counseling
- International trade and national security > Customs, export controls and economic sanctions
- Media, technology and telecoms > Cyber law (including data privacy and data protection)
- Intellectual property > Patents: litigation (International Trade Commission)
- Intellectual property > Patents: prosecution (including re-examination and post-grant proceedings)
- Healthcare > Service providers
- Antitrust > Civil litigation/class actions: defense
- Dispute resolution > Leading trial lawyers
- Dispute resolution > Leading trial lawyers
- M&A/corporate and commercial > M&A: large deals ($1bn+)
- Real estate > Real estate finance
- Finance > Restructuring (including bankruptcy): corporate
- Dispute resolution > Corporate investigations and white-collar criminal defense
- Finance > Financial services regulation